Study points to sanguinarine as histamine buffer in juvenile eels

Version 2

A new Animals study suggests sanguinarine could help protect juvenile American eels from the growth losses and intestinal and hepatic damage associated with excessive dietary histamine. The work focuses on a familiar aquaculture problem: histamine can accumulate in animal-derived feed ingredients, especially lower-quality or poorly handled fishmeal, and sensitive species may pay the price in reduced performance and tissue injury. In this case, the researchers report that adding sanguinarine to a high-histamine diet alleviated at least part of that harm in Anguilla rostrata. (frontiersin.org)

The study lands in the context of a fast-expanding American eel nutrition literature, much of it coming from the same Jimei University group. Just last month, the team published a Frontiers paper showing that juvenile American eels fed diets with histamine levels above 355.31 mg/kg had poorer growth, feed utilization, immune competence, intestinal mucosal integrity, hepatocellular integrity, antioxidant capacity, and digestive enzyme activity than fish on a low-histamine diet. That paper framed histamine as both a feed-safety and economic issue for eel farming, particularly in systems where ingredient quality can vary. (frontiersin.org)

The new sanguinarine paper also fits a broader pattern in eel feeding trials. Earlier studies in juvenile American eels found that other plant-derived compounds, including oligomeric proanthocyanidins and chlorogenic acid, could partly reverse histamine-associated intestinal or metabolic damage. Related work in Animals has also examined low-quality brown fishmeal and additive blends, reinforcing the idea that histamine burden is intertwined with raw-material quality, gut health, and production efficiency in eel culture. (mdpi.com)

Sanguinarine itself is not an unfamiliar molecule in animal nutrition. It is one of the principal benzophenanthridine alkaloids derived from Macleaya cordata, alongside chelerythrine, and reviews describe M. cordata extract as a feed-use product in China with reported applications across livestock and aquaculture. Experimental fish studies have associated sanguinarine or Macleaya cordata extracts with anti-inflammatory, antioxidant, antimicrobial, digestive, and microbiota-modulating effects, though responses vary by species, dose, and formulation. (maxapress.com)

There does not appear to be a separate institutional press release or broad industry response tied specifically to this eel paper in the search results, which is not unusual for a nutrition study in a specialty aquaculture journal. Still, the surrounding literature offers a clear scientific rationale for interest. Histamine has been described as a practical biomarker of feed freshness and safety, and older aquaculture work has linked rising histamine in fishmeal with deteriorating raw-material freshness. From an industry standpoint, that means nutritional mitigation strategies may be useful, but they do not replace feed quality control upstream. (frontiersin.org)

Why it matters: For veterinarians and aquatic animal health teams, the bigger takeaway is that feed-associated gut and liver injury can present as a nutrition and ingredient-quality problem before it looks like an infectious one. In species such as American eel, where fishmeal quality remains important and substitution can be challenging, histamine-related oxidative stress and barrier dysfunction may help explain nonspecific declines in growth, feed conversion, resilience, or mucosal health. Studies like this one may eventually support more targeted feed review, histamine monitoring, and additive selection when working through chronic performance issues on farms. (mdpi.com)

There are also some important caveats. This is still a controlled feeding study, not a field validation in commercial production, and the available search results do not surface independent commentary from outside experts evaluating reproducibility, economics, or residue considerations. And because sanguinarine-containing products can differ in composition and concentration, the practical implications will depend on formulation, inclusion rate, regulatory status in the target market, and species-specific tolerance. That makes the findings promising, but still preliminary from a veterinary decision-making perspective. (sciencedirect.com)

What to watch: Watch for the full paper’s dose details, any follow-on trials in commercial eel systems, and whether future work compares sanguinarine directly with other histamine-mitigation strategies, including ingredient management, histamine thresholds, and alternative functional additives. (frontiersin.org)